Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

About TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cyto…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

31,173

Website

www.tevapharm.com

Fundamentals

1-day range

$36.6$37.83

Market cap

$40.56B

P/E (trailing)

62.45

P/E (forward)

12.18

EPS (trailing)

$0.60

Dividend yield

—

Beta

0.88

Avg. volume

5.81M

Ex-dividend date

November 27, 2017

Dividend pay date

December 12, 2017

Forecasts

10 analyst ratings

Teva Pharmaceutical Industries Limited American Depositary Shares Competitors

Chosen by industry and closest market cap.

• TEVA

  Teva Pharmaceutical Industries Limited American Depositary Shares

  $36.44

  ▼ 3.14%
  Market cap $40.56BP/E 62.45
  $17.77$37.83
• ONC

  BeOne Medicines Ltd. American Depositary Shares

  $366.79

  ▼ 1.53%
  Market cap $36.67BP/E 88.12
  $205.51$346
• ZTS

  Zoetis Inc. Class A Common Stock

  $77.36

  ▲ 3.12%
  Market cap $32.39BP/E 11.54
  $71$156.49
• INSM

  Insmed Incorporated Common Stock

  $118.52

  ▼ 2.36%
  Market cap $28.73BP/E —
  $90.39$212.75
• TAK

  Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

  $18.04

  ▲ 0.06%
  Market cap $53.78BP/E —
  $4,102$6,033
• UTHR

  United Therapeutics Corporation Common Stock

  $515.57

  ▼ 2.34%
  Market cap $22.62BP/E 17.03
  $302.19$609.35
• VTRS

  Viatris Inc. Common Stock

  $16.34

  ▼ 3.26%
  Market cap $18.97BP/E —
  $9.43$18.39

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Alvotech: Reiterate Hold On AVT05/AVT06 BLA Resubmissions And Upcoming Catalysts
  SeekingAlpha · 8/20/2026
• Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug
  Benzinga · 8/20/2026
• Aurinia Settles Teva Patent Litigation, Protecting Voclosporin Exclusivity In U.S. Until December 2036 And Affirming Validity Of Key Patents Through 2037
  Benzinga · 8/19/2026
• Teva Pharmaceuticals' New Drug Application For Ecopipam Gets FDA Acceptance To Treat Pediatric Patients With Tourette Syndrome
  Benzinga · 8/19/2026
• Barclays Maintains Overweight on Teva Pharmaceutical Indus, Raises Price Target to $42
  Benzinga · 8/12/2026
• Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan
  SeekingAlpha · 8/5/2026
• Teva's Re-Rating Still Has Room To Run
  SeekingAlpha · 8/3/2026
• AbbVie: Strong Q2 And New Catalysts Keep Me Bullish
  SeekingAlpha · 8/3/2026

• Tal Zvi Zaks · August 5, 2026 · Sale

  17 @ $34.87
• Placid Jover · August 3, 2026 · Option Exercise

  12.8K
• Placid Jover · August 3, 2026 · Sale

  12.8K @ $34.88
• Eric A. Hughes · August 3, 2026 · Option Exercise

  52.7K
• Eric A. Hughes · August 3, 2026 · Sale

  25.6K @ $34.88
• Matthew Shields · June 18, 2026 · Sale

  10.0K @ $32.19
• Eliyahu Sharon Kalif · June 11, 2026 · Sale

  106.6K @ $34.1
• Chen Lichtenstein · June 5, 2026 · Option Exercise

  14.5K
• Ronit Satchi-Fainaro · June 5, 2026 · Option Exercise

  14.5K
• Amir Elstein · June 5, 2026 · Option Exercise

  14.5K
• Tal Zvi Zaks · June 5, 2026 · Option Exercise

  14.5K
• Perry Nisen · June 5, 2026 · Option Exercise

  14.5K
• Richard D. Francis · June 5, 2026 · Option Exercise

  13.0K
• Richard D. Francis · June 5, 2026 · Sale

  6.2K @ $34.35
• Rosemary A. Crane · June 5, 2026 · Option Exercise

  14.5K

Institutional Ownership

March 31, 2026

Total shares held

697.45M

Total value held

$17.62B

Institutional holders

649